Boehringer Ingelheim International Gmbh - Net Worth and Insider Trading

Boehringer Ingelheim International Gmbh Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Boehringer Ingelheim International Gmbh owns 1 companies in total, including Minerva Neurosciences Inc (NERV) .

Click here to see the complete history of Boehringer Ingelheim International Gmbh’s form 4 insider trades.

Insider Ownership Summary of Boehringer Ingelheim International Gmbh

Ticker	Comapny	Transaction Date	Type of Owner
NERV	Minerva Neurosciences Inc	2023-06-27	10 percent owner

Boehringer Ingelheim International Gmbh Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Boehringer Ingelheim International Gmbh Ownership Network

Ownership Network List of Boehringer Ingelheim International Gmbh

No Data

Ownership Network Relation of Boehringer Ingelheim International Gmbh

Boehringer Ingelheim International Gmbh Owned Company Details

What does Minerva Neurosciences Inc do?

Who are the key executives at Minerva Neurosciences Inc?

Boehringer Ingelheim International Gmbh is the 10 percent owner of Minerva Neurosciences Inc. Other key executives at Minerva Neurosciences Inc include 10 percent owner Ag Boehringer , EVP and Head of R&D Remy Luthringer , and EVP and CFO Geoff Race .

Minerva Neurosciences Inc (NERV) Insider Trades Summary

Over the past 18 months, Boehringer Ingelheim International Gmbh made no insider transaction in Minerva Neurosciences Inc (NERV). Other recent insider transactions involving Minerva Neurosciences Inc (NERV) include a net sale of 27,394 shares made by Remy Luthringer , a net sale of 22,082 shares made by Geoff Race , and a net sale of 3,580 shares made by Frederick W Ahlholm .

In summary, during the past 3 months, insiders sold 0 shares of Minerva Neurosciences Inc (NERV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 53,056 shares of Minerva Neurosciences Inc (NERV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 53,056 shares.

Minerva Neurosciences Inc (NERV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Minerva Neurosciences Inc Insider Transactions

No Available Data

Boehringer Ingelheim International Gmbh Mailing Address

Above is the net worth, insider trading, and ownership report for Boehringer Ingelheim International Gmbh. You might contact Boehringer Ingelheim International Gmbh via mailing address: 200 Park Avenue, C/o Klaus H Jander Esq Rogers & Wells Ll, New York Ny 10166.

Discussions on Boehringer Ingelheim International Gmbh

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.